Media

January 9, 2025: MaaT’s phase 3 GvHD trial hits goal, teeing up microbiome filing if cash crunch clears – Fierce Biotech

Date : January 27, 2025

To see the article click here

January 9, 2025: La biotech lyonnaise MaaT Pharma prouve les vertus du microbiote – Les Echos (French Only)

January 9, 2025: MaaT Prepares For EMA Filing, US Expansion After Positive GVHD Readout – SCRIP